VanEck Video Gaming and eSports ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? VanEck Video Gaming and eSports ETF trades at $100.11 (market cap $248.06M), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 15.4× VanEck Video Gaming and eSports ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Video Gaming and eSports ETF for 66 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| ESPO | RLAY | |
|---|---|---|
Market Cap | $248.06M | $3.82B |
Volume | 13,622 | 4,332,079 |
Sector | Sector/Thematic | Health |
52-Week High | $118.68 | $20.75 |
52-Week Low | $85.25 | $6.03 |
Typical Hold Time | 66 Days | 0 Days |
Enterprise Value | — | $2.93B |
Signals from Pluang's Aura AI — not financial advice
ESPO stock shows strong technical momentum, gaining 2.87% to $100.11 with a bullish moving average signal. The stock trades near resistance levels at $98-$99 while maintaining support at $97. Technical indicators show mixed signals with neutral RSI readings but positive ADX momentum. Fundamental data remains limited pending updated financial disclosures.
The technical setup suggests near-term upside potential if resistance levels are breached, though limited fundamental visibility warrants caution. Key risks include lack of recent financial data and market volatility. Investors require updated earnings reports and analyst coverage for proper valuation assessment before establishing positions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →